Bogart Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Bogart Wealth's REGN Position: Q3 2026 in Review
Bogart Wealth increased its Regeneron Pharmaceuticals (REGN) stake by 41% in Q3 2026, buying an estimated $6.8K and bringing the position to 31 shares worth $23.1K. The position accounts for ﹤0.01% of the portfolio, ranked #782.
Bogart Wealth first reported a position in REGN in Q1 2021 and has held it in 23 quarters since. The position peaked at $29.6K in Q3 2023. 1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Bogart Wealth held 31 shares of Regeneron Pharmaceuticals worth $23.1K as of Q3 2026.
- Bogart Wealth bought 9 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $6.8K.
- Regeneron Pharmaceuticals made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #782 holding.
- Bogart Wealth first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 23 quarters since.
- Bogart Wealth's Regeneron Pharmaceuticals position peaked at $29.6K in Q3 2023.
- 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.